Literature DB >> 15781613

Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.

Lene Uhrbom1, Marianne Kastemar, Fredrik K Johansson, Bengt Westermark, Eric C Holland.   

Abstract

Homozygous deletion of the INK4a-ARF locus is one of the most frequent mutations found in human glioblastoma. We have previously shown that combined Ink4a-Arf loss can increase tumor incidence in both glial progenitor cells and astrocytes during mouse gliomagenesis. Here we have investigated the separate contribution of loss of each of the tumor suppressor genes in glial progenitor cells and astrocytes in Akt + Kras-induced gliomagenesis. We show that Arf is the major tumor suppressor gene in both cell types. Arf loss generated glioblastomas from both nestin-expressing glial progenitor cells and glial fibrillary acidic protein-expressing astrocytes, with a significantly higher incidence in astrocytes. Ink4a loss, on the other hand, could only significantly contribute to gliomagenesis from glial progenitor cells and the induced tumors were of lower malignancy than those seen in Arf-deficient mice. Thus, Ink4a and Arf have independent and differential tumor suppressor functions in vivo in the glial cell compartment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781613     DOI: 10.1158/0008-5472.CAN-04-3588

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

1.  FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes.

Authors:  Bingbing Dai; Russell O Pieper; Dawei Li; Ping Wei; Mingguang Liu; Shiao Y Woo; Kenneth D Aldape; Raymond Sawaya; Keping Xie; Suyun Huang
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

2.  Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis.

Authors:  Lan Mo; Xiaoyong Zheng; Hong-Ying Huang; Ellen Shapiro; Herbert Lepor; Carlos Cordon-Cardo; Tung-Tien Sun; Xue-Ru Wu
Journal:  J Clin Invest       Date:  2007-01-25       Impact factor: 14.808

Review 3.  Brain stem cells as the cell of origin in glioma.

Authors:  Aram S Modrek; N Sumru Bayin; Dimitris G Placantonakis
Journal:  World J Stem Cells       Date:  2014-01-26       Impact factor: 5.326

4.  Spy1 is frequently overexpressed in malignant gliomas and critically regulates the proliferation of glioma cells.

Authors:  Li Zhang; Aiguo Shen; Qing Ke; Wei Zhao; Meijuan Yan; Chun Cheng
Journal:  J Mol Neurosci       Date:  2012-03-25       Impact factor: 3.444

5.  Cell of origin determines tumor phenotype in an oncogenic Ras/p53 knockout transgenic model of high-grade glioma.

Authors:  Sabah O Ghazi; Michelle Stark; Zhiguo Zhao; Bret C Mobley; Alex Munden; Laura Hover; Ty William Abel
Journal:  J Neuropathol Exp Neurol       Date:  2012-08       Impact factor: 3.685

6.  PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation.

Authors:  Yiwen Jiang; Maria Boije; Bengt Westermark; Lene Uhrbom
Journal:  Neoplasia       Date:  2011-06       Impact factor: 5.715

7.  Pten haploinsufficiency accelerates formation of high-grade astrocytomas.

Authors:  Chang-Hyuk Kwon; Dawen Zhao; Jian Chen; Sheila Alcantara; Yanjiao Li; Dennis K Burns; Ralph P Mason; Eva Y-H P Lee; Hong Wu; Luis F Parada
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

8.  H-Ras increases urokinase expression and cell invasion in genetically modified human astrocytes through Ras/Raf/MEK signaling pathway.

Authors:  Yunge Zhao; Aizhen Xiao; Charles G Dipierro; Rana Abdel-Fattah; Samson Amos; Gerard T Redpath; Joan E Carpenter; Russell O Pieper; Isa M Hussaini
Journal:  Glia       Date:  2008-06       Impact factor: 7.452

Review 9.  miRNA-regulated cancer stem cells: understanding the property and the role of miRNA in carcinogenesis.

Authors:  Chiranjib Chakraborty; Kok-Yong Chin; Srijit Das
Journal:  Tumour Biol       Date:  2016-07-28

10.  Histidine-rich glycoprotein can prevent development of mouse experimental glioblastoma.

Authors:  Maria Kärrlander; Nanna Lindberg; Tommie Olofsson; Marianne Kastemar; Anna-Karin Olsson; Lene Uhrbom
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.